OPKO Health, Inc. (OPK)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about OPKO Health, Inc. (OPK)
Company Performance

Current Price

as of Oct 23, 2024

$1.46

P/E Ratio

N/A

Market Cap

$1.02B

Description

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Metrics

Overview

  • HQMiami, FL
  • SectorHealth Services
  • IndustryMedical/Nursing Services
  • TickerOPK
  • Price$1.460.00%

Trading Information

  • Market Cap$1.02B
  • Float46.74%
  • Average Daily Volume (1m)2,626,775
  • Average Daily Volume (3m)3,013,657
  • EPS-$0.33

Company

  • Revenue$716.37M
  • Rev Growth (1yr)-31.36%
  • Net Income-$10.31M
  • Gross Margin17.14%
  • EBITDA Margin-20.59%
  • EBITDA-$37.52M
  • EV$1.10B
  • EV/Revenue1.54
  • P/EN/A
  • P/S1.42
  • P/B0.73
Documents
SEC Filings
8-K (2024-09-16)
8-K (2024-08-07)
8-K (2024-07-29)
8-K (2024-07-17)
8-K (2024-05-07)
8-K (2024-03-29)
8-K (2024-03-28)
8-K (2024-02-27)
8-K (2024-02-09)
8-K (2024-01-24)
8-K (2024-01-09)
8-K (2024-01-05)
8-K (2024-01-04)
8-K (2023-11-06)
8-K (2023-09-28)
8-K (2023-08-03)
8-K (2023-06-30)
8-K (2023-06-23)
8-K (2023-05-19)
8-K (2023-05-03)
8-K (2023-03-08)
8-K (2023-02-23)
8-K (2023-02-10)
8-K (2023-01-03)
10-Q (2024-08-07)
10-Q (2024-05-07)
10-Q (2023-11-06)
10-Q (2023-08-03)
10-Q (2023-05-03)
10-K (2024-03-01)
10-K (2023-02-27)
Earnings Calls
Earnings Report 2024Q2
Earnings Report 2024Q1
Earnings Report (2023-11-06)
Earnings Report (2023-08-04)
Factset
Factset Business Description
Wikipedia
OPKO_Health,_Inc.
Factset Street Account
StreetAccount Metrics Recap - Opko Health Q3 Earnings ($1.34, 0.00) (2023-11-06T21:18:44Z)
StreetAccount Earnings Call Q&A Summary: Opko Health Q3 ($1.34, 0.00) (2023-11-06T23:02:32Z)
StreetAccount Consensus Metrics Preview - Opko Health Q3 Earnings ($1.35, +0.07) (2023-11-03T17:01:31Z)
OPKO Health to present new clinical data on Rayaldee (ER Calcifediol) at Kidney Week 2023 ($1.27, 0.00) (2023-10-25T20:28:32Z)
Opko Health reports Q3 EPS ($0.11) vs FactSet ($0.10) [6 est, ($0.16)-(0.08)] ($1.34, 0.00) (2023-11-06T21:16:43Z)
Opko Health presents new clinical data on RAYALDEE (ER Calcifediol) at Kidney Week 2023 ($1.28, +0.03) (2023-11-02T14:01:44Z)